1-1 of 1
Kentaro Bandobashi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Anti-Tumor Effects of SU11248, a Class III Receptor Tyrosine Kinase Inhibitor, Against a Variety of Human Hematological Malignancies.

Takayuki Ikezoe, MD, Kentaro Bandobashi, MD, Yang Yang, Tsuyako Saito, MD, Kazuto Togitani, MD, Taizo Tasaka, MD, H. Phillip Koeffler, MD, Hirokuni Taguchi, MD
Journal: Blood
Blood (2005) 106 (11): 2795.
https://doi.org/10.1182/blood.V106.11.2795.2795
Published: 2005